OVESTIN Israele - inglese - Ministry of Health

ovestin

padagis israel agencies ltd, israel - estriol - cream - estriol 0.1 % - estriol - for the treatment of vulvo-vaginal complaints related to estrogen deficiency.

CONCOR 10 MG Israele - inglese - Ministry of Health

concor 10 mg

merck serono ltd - bisoprolol fumarate - tablets - bisoprolol fumarate 10 mg - bisoprolol - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension- coronary heart disease (angina pectoris)

CONCOR 5 MG Israele - inglese - Ministry of Health

concor 5 mg

merck serono ltd - bisoprolol fumarate - tablets - bisoprolol fumarate 5 mg - bisoprolol - - treatment of stable chronic, moderate to severe heart failure with impaired systolic ventricular function ( ejection fraction < 35 %, determined by echocardiography) in addition to ace inhibitors and diuretics, and optionally cardiac glycosides.- hypertension- coronary heart disease (angina pectoris)

PAXXET 20 Israele - inglese - Ministry of Health

paxxet 20

unipharm ltd, israel - paroxetine as hydrochloride - tablets - paroxetine as hydrochloride 20 mg - paroxetine - paroxetine - treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. treatment of symptoms and prevention of relapse of obsessive compulsive disorder (ocd). treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.treatment of symptoms of social phobia.

PAXXET 30 Israele - inglese - Ministry of Health

paxxet 30

unipharm ltd, israel - paroxetine as hydrochloride - tablets - paroxetine as hydrochloride 30 mg - paroxetine - paroxetine - treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. treatment of symptoms and prevention of relapse of obsessive compulsive disorder (ocd). treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.treatment of symptoms of social phobia.

INTELENCE 200 MG Israele - inglese - Ministry of Health

intelence 200 mg

j-c health care ltd - etravirine - tablets - etravirine 200 mg - etravirine - etravirine - intelence is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-experienced adult patients including those with non-nucleoside reverse transcriptase inhibitor (nnrti) resistance. treatment history and when available resistance testing should guide the use of intelence. in patients who have experienced virological failure on an nnrti- and nucleoside or nucleotide reverse transcriptase inhibitor (n[t]rti)- containing regimen intelence is not recommended for use in combination with n(t)rtis only.

AMLOW 5 Israele - inglese - Ministry of Health

amlow 5

unipharm ltd, israel - amlodipine as maleate - tablets - amlodipine as maleate 5 mg - amlodipine - amlodipine - mild to moderate hypertension. vasospastic angina (prinzmetal's or variant angina). chronic stable angina.

AMLOW 10 Israele - inglese - Ministry of Health

amlow 10

unipharm ltd, israel - amlodipine as maleate - tablets - amlodipine as maleate 10 mg - amlodipine - amlodipine - mild to moderate hypertension. vasospastic angina (prinzmetal's or variant angina). chronic stable angina.

AKNEMYCIN PLUS Israele - inglese - Ministry of Health

aknemycin plus

neopharm ltd - erythromycin; tretinoin - solution - erythromycin 4 g / 100 g; tretinoin 0.025 g / 100 g - erythromycin, combinations - erythromycin, combinations - all forms of acne, both non-inflammatory forms with comedones and inflammatory forms with papules and pustules, particularly in the case of fat-rich skin.

FEMARA Israele - inglese - Ministry of Health

femara

novartis israel ltd - letrozole - film coated tablets - letrozole 2.5 mg - letrozole - letrozole - femara (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. femara is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.